Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults

  1. Flavia Camponovo
  2. Joseph J Campo
  3. Timothy Q Le
  4. Amit Oberai
  5. Christopher Hung
  6. Jozelyn V Pablo
  7. Andy A Teng
  8. Xiaowu Liang
  9. B Kim Lee Sim
  10. Said Jongo
  11. Salim Abdulla
  12. Marcel Tanner
  13. Stephen L Hoffman
  14. Claudia Daubenberger
  15. Melissa A Penny  Is a corresponding author
  1. Swiss Tropical and Public Health Institute, Switzerland
  2. Antigen Discovery Inc, United States
  3. Sanaria Inc, United States
  4. Ifakara Health Institute, United Republic of Tanzania
  5. University of Basel, Switzerland

Abstract

Tanzanian adult male volunteers were immunized by direct venous inoculation with radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum (Pf) sporozoites (PfSPZ Vaccine) and protective efficacy assessed by homologous controlled human malaria infection (CHMI). Serum immunoglobulin G (IgG) responses were analyzed longitudinally using a Pf protein microarray covering 91% of the proteome, providing first insights into naturally acquired and PfSPZ Vaccine-induced whole parasite antibody profiles in malaria pre-exposed Africans. Immunoreactivity was identified against 2,239 functionally diverse Pf proteins, showing a wide breadth of humoral response. Antibody-based immune 'fingerprints' in these individuals indicated a strong person-specific immune response at baseline, with little changes in the overall humoral immunoreactivity pattern measured after immunization. The moderate increase in immunogenicity following immunization and the extensive and variable breadth of humoral immune response observed in the volunteers at baseline suggest that pre-exposure reduces vaccine-induced antigen reactivity in unanticipated ways.

Data availability

All data analyzed during this study are included in the manuscript and supporting files, or sited accordingly when published elsewhere

Article and author information

Author details

  1. Flavia Camponovo

    Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    Competing interests
    No competing interests declared.
  2. Joseph J Campo

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Joseph J Campo, is an employee of Antigen Discovery, Inc.
  3. Timothy Q Le

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Timothy Q Le, is an employee of Antigen Discovery, Inc.
  4. Amit Oberai

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Amit Oberai, is an employee of Antigen Discovery, Inc.
  5. Christopher Hung

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Christopher Hung, is an employee of Antigen Discovery, Inc.
  6. Jozelyn V Pablo

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Jozelyn V Pablo, is an employee of Antigen Discovery, Inc.
  7. Andy A Teng

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Andy A Teng, is an employee of Antigen Discovery, Inc.
  8. Xiaowu Liang

    Antigen Discovery Inc, Irvine, United States
    Competing interests
    Xiaowu Liang, is an employee of Antigen Discovery, Inc.
  9. B Kim Lee Sim

    Process Development and Manufacturing, Sanaria Inc, Rockville, United States
    Competing interests
    B Kim Lee Sim, This author is affiliated with Sanaria Inc. Sanaria manufactured PfSPZ Vaccine and PfSPZ Challenge.
  10. Said Jongo

    Interventions and Clinical Trials Unit, Bagamoyo Branch, Ifakara Health Institute, Dar es Salam, United Republic of Tanzania
    Competing interests
    No competing interests declared.
  11. Salim Abdulla

    Interventions and Clinical Trials Unit, Bagamoyo Branch, Ifakara Health Institute, Dar es Salam, United Republic of Tanzania
    Competing interests
    No competing interests declared.
  12. Marcel Tanner

    Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    Competing interests
    No competing interests declared.
  13. Stephen L Hoffman

    Process Development and Manufacturing, Sanaria Inc, Rockville, United States
    Competing interests
    Stephen L Hoffman, This author is employed by Sanaria. Sanaria Inc. manufactured PfSPZ Vaccine and PfSPZ Challenge. Thus, all authors associated with Sanaria have potential conflicts of interest..
  14. Claudia Daubenberger

    University of Basel, Basel, Switzerland
    Competing interests
    No competing interests declared.
  15. Melissa A Penny

    Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    For correspondence
    melissa.penny@unibas.ch
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4972-593X

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_170702)

  • Melissa A Penny

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Urszula Krzych, Walter Reed Army Institute of Research, United States

Version history

  1. Received: October 26, 2019
  2. Accepted: July 10, 2020
  3. Accepted Manuscript published: July 14, 2020 (version 1)
  4. Version of Record published: July 28, 2020 (version 2)

Copyright

© 2020, Camponovo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,528
    views
  • 191
    downloads
  • 18
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Flavia Camponovo
  2. Joseph J Campo
  3. Timothy Q Le
  4. Amit Oberai
  5. Christopher Hung
  6. Jozelyn V Pablo
  7. Andy A Teng
  8. Xiaowu Liang
  9. B Kim Lee Sim
  10. Said Jongo
  11. Salim Abdulla
  12. Marcel Tanner
  13. Stephen L Hoffman
  14. Claudia Daubenberger
  15. Melissa A Penny
(2020)
Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults
eLife 9:e53080.
https://doi.org/10.7554/eLife.53080

Share this article

https://doi.org/10.7554/eLife.53080

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Patrick E Brown, Sze Hang Fu ... Ab-C Study Collaborators
    Research Article

    Background: Few national-level studies have evaluated the impact of 'hybrid' immunity (vaccination coupled with recovery from infection) from the Omicron variants of SARS-CoV-2.

    Methods: From May 2020 to December 2022, we conducted serial assessments (each of ~4000-9000 adults) examining SARS-CoV-2 antibodies within a mostly representative Canadian cohort drawn from a national online polling platform. Adults, most of whom were vaccinated, reported viral test-confirmed infections and mailed self-collected dried blood spots to a central lab. Samples underwent highly sensitive and specific antibody assays to spike and nucleocapsid protein antigens, the latter triggered only by infection. We estimated cumulative SARS-CoV-2 incidence prior to the Omicron period and during the BA.1/1.1 and BA.2/5 waves. We assessed changes in antibody levels and in age-specific active immunity levels.

    Results: Spike levels were higher in infected than in uninfected adults, regardless of vaccination doses. Among adults vaccinated at least thrice and infected more than six months earlier, spike levels fell notably and continuously for the nine months post-vaccination. By contrast, among adults infected within six months, spike levels declined gradually. Declines were similar by sex, age group, and ethnicity. Recent vaccination attenuated declines in spike levels from older infections. In a convenience sample, spike antibody and cellular responses were correlated. Near the end of 2022, about 35% of adults above age 60 had their last vaccine dose more than six months ago, and about 25% remained uninfected. The cumulative incidence of SARS-CoV-2 infection rose from 13% (95% CI 11-14%) before omicron to 78% (76-80%) by December 2022, equating to 25 million infected adults cumulatively. However, the COVID-19 weekly death rate during the BA.2/5 waves was less than half of that during the BA.1/1.1 wave, implying a protective role for hybrid immunity.

    Conclusions: Strategies to maintain population-level hybrid immunity require up-to-date vaccination coverage, including among those recovering from infection. Population-based, self-collected dried blood spots are a practicable biological surveillance platform.

    Funding: Funding was provided by the COVID-19 Immunity Task Force, Canadian Institutes of Health Research, Pfizer Global Medical Grants, and St. Michael's Hospital Foundation. PJ and ACG are funded by the Canada Research Chairs Program.

    1. Computational and Systems Biology
    2. Epidemiology and Global Health
    Javier I Ottaviani, Virag Sagi-Kiss ... Gunter GC Kuhnle
    Research Article

    The chemical composition of foods is complex, variable, and dependent on many factors. This has a major impact on nutrition research as it foundationally affects our ability to adequately assess the actual intake of nutrients and other compounds. In spite of this, accurate data on nutrient intake are key for investigating the associations and causal relationships between intake, health, and disease risk at the service of developing evidence-based dietary guidance that enables improvements in population health. Here, we exemplify the importance of this challenge by investigating the impact of food content variability on nutrition research using three bioactives as model: flavan-3-ols, (–)-epicatechin, and nitrate. Our results show that common approaches aimed at addressing the high compositional variability of even the same foods impede the accurate assessment of nutrient intake generally. This suggests that the results of many nutrition studies using food composition data are potentially unreliable and carry greater limitations than commonly appreciated, consequently resulting in dietary recommendations with significant limitations and unreliable impact on public health. Thus, current challenges related to nutrient intake assessments need to be addressed and mitigated by the development of improved dietary assessment methods involving the use of nutritional biomarkers.